Document is current
Any future updates will be listed below
-
Authors
Voos, Kayleigh M.
Tzeng, Joyce
Patel, Priya https://orcid.org/0009-0007-5572-1170
Rubinsky, Sophie
Choi, Ha E. https://orcid.org/0009-0000-3990-1146
Pharr, Trevor
Sookram, Sebastian https://orcid.org/0009-0005-1966-1639
Baur, Joseph A. https://orcid.org/0000-0001-8262-6549
Soderblom, Erik J.
Lorenzo, Damaris N. https://orcid.org/0000-0002-6856-2988
-
Funding
Funding for this research was provided by:
American Diabetes Association (1-19-JDF-081)
U.S. Department of Health & Human Services | National Institutes of Health (R01NS110810, R01MH127848, R01HL165792, R01DK098656)
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 30 July 2025
First Online: 25 August 2025
Competing interests
: J.A.B. has received research funding and/or materials from Pfizer, Elysium Health, Chromadex, and Metro International Biotech, and consulting fees from Pfizer, Elysium Health, Cytokinetics and Altimmune, and is an inventor on a patent for the use of NAD+ precursors to promote liver regeneration (US no. 16/078,446; “Methods for Enhancing Liver Regeneration”). All other authors declare no competing interests.
